Risk factors modification in atrial fibrillation: a brief review

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart association. Circulation. 2018;137(12):e67–e492. doi: 10.1161/CIR.0000000000000558
   PubMed Web of Science ®Google Scholar
• Colilla S, Crow A, Petkun W, et al. Estimates of Current and future incidence and prevalence of atrial fibrillation in the U.S. Adult population. Am J Cardiol. 2013;112(8):1142–1147. doi: 10.1016/j.amjcard.2013.05.063
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Soc Cardiol. 2016;50(5):e1–e88. doi: 10.1093/ejcts/ezw313
   Google Scholar
• Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275–e444.
   PubMed Web of Science ®Google Scholar
• Nattel S. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol. 2017;3(5):425–435. doi: 10.1016/j.jacep.2017.03.002
   PubMedGoogle Scholar
• Karason K, Mølgaard H, Wikstrand J, et al. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol. 1999;83(8):1242–1247. doi: 10.1016/s0002-9149(99)00066-1
   PubMed Web of Science ®Google Scholar
• Russo C, Jin Z, Homma S, et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol. 2011;57(12):1368–1374. doi: 10.1016/j.jacc.2010.10.042
   PubMed Web of Science ®Google Scholar
• Wong CX, Sun MT, Odutayo A, et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(12):e004378. doi: 10.1161/CIRCEP.116.004378
   PubMed Web of Science ®Google Scholar
• Alaud-Din A, Meterissian S, Lisbona R, et al. Assessment of cardiac function in patients who were morbidly obese. Surgery. 1990;108(4): 809–818. discussion 818-820.
   PubMed Web of Science ®Google Scholar
• Tedrow UB, Conen D, Ridker PM, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol. 2010;55(21):2319–2327. doi: 10.1016/j.jacc.2010.02.029
   PubMed Web of Science ®Google Scholar
• Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117(10):1255–1260. doi: 10.1161/CIRCULATIONAHA.107.744466
   PubMed Web of Science ®Google Scholar
• Berkovitch A, Kivity S, Klempfner R, et al. Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults. Am Heart J. 2016;173:41–48. doi: 10.1016/j.ahj.2015.11.016
   PubMed Web of Science ®Google Scholar
• Jamaly S, Carlsson L, Peltonen M, et al. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68(23):2497–2504. doi: 10.1016/j.jacc.2016.09.940
   PubMed Web of Science ®Google Scholar
• Foy AJ, Mandrola J, Liu G, et al. Relation of obesity to New-onset atrial fibrillation and atrial flutter in adults. Am J Cardiol. 2018;121(9):1072–1075. doi: 10.1016/j.amjcard.2018.01.019
   PubMed Web of Science ®Google Scholar
• Jones NR, Taylor KS, Taylor CJ, et al. Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis. Heart Br Cardiol Soc. 2019;105(23):1799–1805. doi: 10.1136/heartjnl-2019-314931
   Google Scholar
• Tsang TSM, Barnes ME, Miyasaka Y, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29(18):2227–2233. doi: 10.1093/eurheartj/ehn324
   PubMed Web of Science ®Google Scholar
• Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–2060. doi: 10.1001/jama.2013.280521
   PubMed Web of Science ®Google Scholar
• Abed HS, Nelson AJ, Richardson JD, et al. Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation. Am Heart J. 2015;169(5):655–662.e2. doi: 10.1016/j.ahj.2015.02.008
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–2231. doi: 10.1016/j.jacc.2014.09.028
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–2169. doi: 10.1016/j.jacc.2015.03.002
   PubMed Web of Science ®Google Scholar
• Pathak RK, Elliott A, Middeldorp ME, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66(9):985–996. doi: 10.1016/j.jacc.2015.06.488
   PubMed Web of Science ®Google Scholar
• Gessler N, Willems S, Steven D, et al. Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial. EP Europace. 2021 Oct 9;23(10):1548–1558. doi: 10.1093/europace/euab122
   PubMed Web of Science ®Google Scholar
• Donnellan E, Wazni O, Kanj M, et al. Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort. Circ Arrhythm Electrophysiol. 2019;12(10):e007598. doi: 10.1161/CIRCEP.119.007598
   PubMed Web of Science ®Google Scholar
• Dzeshka MS, Shantsila A, Shantsila E, et al. Atrial fibrillation and hypertension. Hypertens Dallas Tex 1979. 2017;70(5):854–861. doi: 10.1161/HYPERTENSIONAHA.117.08934
   Google Scholar
• Shaikh AY, Wang N, Yin X, et al. Relations of arterial stiffness and brachial flow–mediated dilation with New-onset atrial fibrillation. Hypertension. 2016;68(3):590–596. doi: 10.1161/HYPERTENSIONAHA.116.07650
   PubMed Web of Science ®Google Scholar
• Okin PM, Hille DA, Larstorp ACK, et al. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients. Hypertens Dallas Tex 1979. 2015;66(2):368–373. doi: 10.1161/HYPERTENSIONAHA.115.05728
   Google Scholar
• Zhang Y, Zhang P, Mu Y, et al. The role of renin–angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Pharmacol Ther. 2010;88(4):521–531. doi: 10.1038/clpt.2010.123
   PubMed Web of Science ®Google Scholar
• Nasr IA, Bouzamondo A, Hulot JS, et al. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J. 2007;28(4):457–462. doi: 10.1093/eurheartj/ehl484
   PubMed Web of Science ®Google Scholar
• Kühlkamp V, Schirdewan A, Stangl K, et al. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2000;36(1):139–146. doi: 10.1016/s0735-1097(00)00693-8
   PubMed Web of Science ®Google Scholar
• Madrid AH, Bueno MG, Rebollo JMG, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 2002;106(3):331–336. doi: 10.1161/01.cir.0000022665.18619.83
   PubMed Web of Science ®Google Scholar
• Ueng KC, Tsai TP, Yu WC, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J. 2003;24(23):2090–2098. doi: 10.1016/j.ehj.2003.08.014
   PubMed Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Katritsis DG, et al. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11(7):1131–1138. doi: 10.1016/j.hrthm.2014.03.055
   PubMed Web of Science ®Google Scholar
• Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571. doi: 10.1016/j.jacc.2006.08.060
   PubMed Web of Science ®Google Scholar
• Youssef I, Kamran H, Yacoub M, et al. Obstructive Sleep Apnea as a Risk Factor for Atrial Fibrillation: A Meta-Analysis. J Sleep Disord Ther. 2018;7(1):282. doi: 10.4172/2167-0277.1000282
   PubMedGoogle Scholar
• Qureshi WT, Nasir UB, Alqalyoobi S, et al. Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol. 2015;116(11):1767–1773. doi: 10.1016/j.amjcard.2015.08.046
   PubMed Web of Science ®Google Scholar
• Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2. doi: 10.1016/j.ahj.2014.12.024
   PubMed Web of Science ®Google Scholar
• Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305. doi: 10.1016/j.jacc.2013.03.052
   PubMed Web of Science ®Google Scholar
• Hojo R, Fukamizu S, Miyazawa S, et al. The relationship between obstructive sleep apnea and recurrence of atrial fibrillation after pulmonary vein isolation using a contact force–sensing catheter. J Interv Card Electrophysiol. 2019 Apr;54(3):209–215. doi: 10.1007/s10840-018-0489-x
   PubMed Web of Science ®Google Scholar
• Matiello M, Nadal M, Tamborero D, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010 Aug;12(8):1084–1089. doi: 10.1093/europace/euq128
   PubMed Web of Science ®Google Scholar
• Naruse Y, Tada H, Satoh M, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10(3):331–337. doi: 10.1016/j.hrthm.2012.11.015
   PubMed Web of Science ®Google Scholar
• Wang A, Green JB, Halperin JL, et al. Atrial fibrillation and diabetes mellitus: JACC review Topic of the Week. J Am Coll Cardiol. 2019;74(8):1107–1115. doi: 10.1016/j.jacc.2019.07.020
   PubMed Web of Science ®Google Scholar
• Huxley RR, Filion KB, Konety S, et al. Meta-analysis of cohort and case–control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56–62. doi: 10.1016/j.amjcard.2011.03.004
   PubMed Web of Science ®Google Scholar
• Dublin S, Glazer NL, Smith NL, et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853–858. doi: 10.1007/s11606-010-1340-y
   PubMed Web of Science ®Google Scholar
• Chang SH, Wu LS, Chiou MJ, et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol. 2014;13(1):123. doi: 10.1186/s12933-014-0123-x
   PubMed Web of Science ®Google Scholar
• Zelniker TA, Bonaca MP, Furtado RHM, et al. Effect of Dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation. 2020;141(15):1227–1234. doi: 10.1161/CIRCULATIONAHA.119.044183
   PubMed Web of Science ®Google Scholar
• Kishima H, Mine T, Fukuhara E, et al. Efficacy of sodium-glucose cotransporter 2 inhibitors on outcomes after catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2022;8(11):1393–1404. doi: 10.1016/j.jacep.2022.08.004
   PubMedGoogle Scholar
• Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study. Heart Rhythm. 2011;8(8):1160–1166. doi: 10.1016/j.hrthm.2011.03.038
   PubMed Web of Science ®Google Scholar
• Fukamizu S, Sakurada H, Takano M, et al. Effect of Cigarette smoking on the risk of atrial fibrillation recurrence after pulmonary vein isolation. J Arrhythmia. 2010;26(1):21–29. doi: 10.1016/S1880-4276(10)80032-8
   Google Scholar
• Cheng WH, Lo LW, Lin YJ, et al. Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation. J Cardiovasc Electrophysiol. 2018;29(5):699–706. doi: 10.1111/jce.13451
   PubMed Web of Science ®Google Scholar
• Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64(3):281–289. doi: 10.1016/j.jacc.2014.03.048
   PubMed Web of Science ®Google Scholar
• Qiao Y, Shi R, Hou B, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4(11):e002349. doi: 10.1161/JAHA.115.002349
   PubMed Web of Science ®Google Scholar
• Voskoboinik A, Prabhu S, Ling LH, et al. Alcohol and atrial fibrillation: a sobering review. J Am Coll Cardiol. 2016;68(23):2567–2576. doi: 10.1016/j.jacc.2016.08.074
   PubMed Web of Science ®Google Scholar